These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 7482387)

  • 1. Excitatory amino acid receptors and neurodegeneration.
    Doble A
    Therapie; 1995; 50(4):319-37. PubMed ID: 7482387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.
    Heath PR; Shaw PJ
    Muscle Nerve; 2002 Oct; 26(4):438-58. PubMed ID: 12362409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of excitatory amino acids in neuropathology].
    Wikinski SI; Acosta GB
    Medicina (B Aires); 1995; 55(4):355-65. PubMed ID: 8728878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of glutamate and excitotoxicity in neurologic diseases].
    Hugon J; Vallat JM; Dumas M
    Rev Neurol (Paris); 1996 Apr; 152(4):239-48. PubMed ID: 8763652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemical biology of clinically tolerated NMDA receptor antagonists.
    Chen HS; Lipton SA
    J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamatergic mechanisms in different disease states: overview and therapeutical implications -- an introduction.
    Tzschentke TM
    Amino Acids; 2002; 23(1-3):147-52. PubMed ID: 12373529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMPA receptor regulation mechanisms: future target for safer neuroprotective drugs.
    Jayakar SS; Dikshit M
    Int J Neurosci; 2004 Jun; 114(6):695-734. PubMed ID: 15204061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The N-methyl-D-aspartate receptor complex. Various sites of regulation and clinical consequences].
    Turski L
    Arzneimittelforschung; 1990 May; 40(5):511-4. PubMed ID: 1974426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs.
    Bruno V; Battaglia G; Copani A; D'Onofrio M; Di Iorio P; De Blasi A; Melchiorri D; Flor PJ; Nicoletti F
    J Cereb Blood Flow Metab; 2001 Sep; 21(9):1013-33. PubMed ID: 11524608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excitatory amino acids: function and significance in reproduction and neuroendocrine regulation.
    Brann DW; Mahesh VB
    Front Neuroendocrinol; 1994 Mar; 15(1):3-49. PubMed ID: 7958168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of NMDA and AMPA/kainate receptor antagonists on nitric oxide production in rat brain following intrahippocampal injection.
    Radenovic L; Selakovic V
    Brain Res Bull; 2005 Sep; 67(1-2):133-41. PubMed ID: 16140172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
    Beal MF
    Ann Neurol; 1992 Feb; 31(2):119-30. PubMed ID: 1349466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporospatial coupling of networked synaptic activation of AMPA-type glutamate receptor channels and calcium transients in cultured motoneurons.
    Jahn K; Grosskreutz J; Haastert K; Ziegler E; Schlesinger F; Grothe C; Dengler R; Bufler J
    Neuroscience; 2006 Nov; 142(4):1019-29. PubMed ID: 16949760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning of the genes for excitatory amino acid receptors.
    Henneberry RC
    Bioessays; 1992 Jul; 14(7):465-71. PubMed ID: 1359885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of excitotoxicity in neurodegenerative disease: implications for therapy.
    Doble A
    Pharmacol Ther; 1999 Mar; 81(3):163-221. PubMed ID: 10334661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of neurotoxins with non-NMDA glutamate receptors: an autoradiographic study.
    Künig G; Niedermeyer B; Krause F; Hartmann J; Deckert J; Ransmayr G; Heinsen H; Beckmann H; Riederer P
    J Neural Transm Suppl; 1994; 43():59-62. PubMed ID: 7533823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response properties of antral mechanosensitive afferent fibers and effects of ionotropic glutamate receptor antagonists.
    Sengupta JN; Petersen J; Peles S; Shaker R
    Neuroscience; 2004; 125(3):711-23. PubMed ID: 15099685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of action of neuroprotectants in stroke.
    Lyden P; Wahlgren NG
    J Stroke Cerebrovasc Dis; 2000 Nov; 9(6 Pt 2):9-14. PubMed ID: 17895214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kainate receptors mediate a slow postsynaptic current in hippocampal CA3 neurons.
    Castillo PE; Malenka RC; Nicoll RA
    Nature; 1997 Jul; 388(6638):182-6. PubMed ID: 9217159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamate-based therapeutic approaches: NR2B receptor antagonists.
    Gogas KR
    Curr Opin Pharmacol; 2006 Feb; 6(1):68-74. PubMed ID: 16376149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.